क्यूआर कोड

Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data

Abstract The PATRICIA study (NCT02536339) examined the efficacy and safety of pertuzumab plus high-dose trastuzumab in patients with HER2-positive metastatic breast cancer (MBC) with progressive central nervous system (CNS) metastases following radiotherapy. Primary analysis confirmed CNS objective...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Nancy U. Lin, Priya Kumthekar, Solmaz Sahebjam, Nuhad Ibrahim, Anita Fung, Anna Cheng, Alan Nicholas, Jesse Sussell, Mark Pegram
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Portfolio 2023-11-01
श्रृंखला:npj Breast Cancer
ऑनलाइन पहुंच:https://doi.org/10.1038/s41523-023-00587-2
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन